Information updates

Updated translations of ASCIA anaphylaxis information

August 4, 2017

To support patients with severe allergies and their carers, and provide resources for health professionals, updated translations of ASCIA anaphylaxis information have been developed. These translations (into 16 languages) were funded by an educational grant from the Sydney Children's Hospitals Network (SCHN).

The following translations are now available on the ASCIA website

Anaphylaxis is a potentially life threatening, severe allergic reaction and should always be treated as a medical emergency. Anaphylaxis occurs after exposure to an allergen (usually to foods, insects or medicines), to which a person is allergic.

Adrenaline (epinephrine) is the first line treatment for anaphylaxis.  Adrenaline works rapidly to reverse the effects of anaphylaxis and is the first line treatment for anaphylaxis. Adrenaline autoinjectors contain a single, fixed dose of adrenaline, and have been designed to be given by non-medical people, such as a friend, teacher, childcare worker, parent, passer-by or by the patient themselves (if they are not too unwell to do this).

For additional information on anaphylaxis go to